Push Admin

Palace open to Dengvaxia return as long as it benefits Pinoys

Article (news)

Arianne Merez, ABS-CBN News

MANILA- The Philippine government is open to the idea of making the controversial dengue vaccine, Dengvaxia, available again in the market as long as there is enough proof that the drug will benefit Filipinos.Presidential Spokesman Salvador Panelo said the government should consider making Dengvaxia available to the public anew if there are enough findings to support its effectivity and safety.“We’re always open to anything that will benefit the Filipino people. We’re not closed to any suggestion,” Panelo told reporters on Wednesday.“If the weight of the findings show that there is benefit in using Dengvaxia against dengue then certainly government should consider it,” he said.In December 2017, the government recalled Dengvaxia after its manufacturer, France&#x27;s Sanofi-Pasteur, said it could cause severe symptoms if given to those who have not had the mosquito-borne disease.The vaccine recall triggered a <a href="https://news.abs-cbn.com/news/12/27/18/big-challenge-for-doh-restoring-trust-in-vaccines-after-dengvaxia-scare">public health scare</a> which resulted in a drop of vaccination rate in the Philippines. Several cases have also been filed over the deaths of some who were injected with Dengvaxia, but it has not been established whether the fatalities were caused by the vaccine.Last week, former Health Secretary and now Iloilo Rep. Janette Garin urged the Department of Health to make the vaccine available in the country anew amid the rising number of dengue cases.She was among those who faced the nationally televised hearings on Dengvaxia, which was given to some 830,000 school children during the term of former President Benigno &quot;Noynoy&quot; Aquino III.

The Philippine government is open to the idea of making the controversial dengue vaccine, Dengvaxia, available again in the market as long as there is enough proof that the drug will benefit Filipinos.

The Philippine government is open to the idea of making the controversial dengue vaccine, Dengvaxia, available again in the market as long as there is enough proof that the drug will benefit Filipinos.

Palace open to Dengvaxia return as long as it benefits Pinoys

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

News

Palace open to Dengvaxia return as long as it benefits Pinoys

Arianne Merez,

ABS-CBN News

Published Jul 31, 2019 04:54 PM PHT

|

Updated Aug 02, 2019 04:39 AM PHT

Read More:

Dengvaxia

dengue vaccine

Malacañang

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.